These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

77 related articles for article (PubMed ID: 12211397)

  • 21. Production and application of recombinant antibodies to foot-and-mouth disease virus non-structural protein 3ABC.
    Foord AJ; Muller JD; Yu M; Wang LF; Heine HG
    J Immunol Methods; 2007 Apr; 321(1-2):142-51. PubMed ID: 17328909
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [The effectiveness of vaccination to prevent foot and mouth disease in several species].
    Orsel K
    Tijdschr Diergeneeskd; 2008 Jan; 133(1):14-6. PubMed ID: 18260556
    [No Abstract]   [Full Text] [Related]  

  • 23. Animal health and the E.E.C.
    Brown AC
    Vet Rec; 1973 Dec; 93(22):574-6. PubMed ID: 4785346
    [No Abstract]   [Full Text] [Related]  

  • 24. Experimental studies with foot-and-mouth disease virus type Asia-1, responsible for the 2005 epidemic in China.
    Zhang Q; Li D; Liu X; Liu Z; Cai X; Wu G; Qi S; Yang S; Yan X; Shang Y; He J; Ma J; Li J; Ma W; Han R; Liu X; Zhang J; Xie Q; Zhang Z
    Res Vet Sci; 2008 Oct; 85(2):368-71. PubMed ID: 18155114
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Need for vigilance in the aftermath of FMD and CSF.
    Blowey RW
    Vet Rec; 2002 Mar; 150(13):420. PubMed ID: 11999288
    [No Abstract]   [Full Text] [Related]  

  • 26. [Economic effectiveness of anti-foot-and-mouth disease measures].
    Shchelokov NA
    Veterinariia; 1972 Jan; 1():41-2. PubMed ID: 4269448
    [No Abstract]   [Full Text] [Related]  

  • 27. Cedivac-FMD can be used according to a marker vaccine principle.
    Chénard G; Selman P; Dekker A
    Vet Microbiol; 2008 Apr; 128(1-2):65-71. PubMed ID: 18035508
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A dynamic, optimal disease control model for foot-and-mouth disease: I. Model description.
    Kobayashi M; Carpenter TE; Dickey BF; Howitt RE
    Prev Vet Med; 2007 May; 79(2-4):257-73. PubMed ID: 17280729
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Re-emergence of foot-and-mouth disease in Botswana.
    Baipoledi EK; Matlho G; Letshwenyo M; Chimbombi M; Adom EK; Raborokgwe MV; Hyera JM
    Vet J; 2004 Jul; 168(1):93-9. PubMed ID: 15158214
    [TBL] [Abstract][Full Text] [Related]  

  • 30. An approach to a FMD vaccine based on genetic engineered attenuated pseudorabies virus: one experiment using VP1 gene alone generates an antibody responds on FMD and pseudorabies in swine.
    Qian P; Li XM; Jin ML; Peng GQ; Chen HC
    Vaccine; 2004 Jun; 22(17-18):2129-36. PubMed ID: 15149769
    [TBL] [Abstract][Full Text] [Related]  

  • 31. FMD and the contiguous cull.
    Clayton N
    Vet Rec; 2006 Dec; 159(23):787. PubMed ID: 17142633
    [No Abstract]   [Full Text] [Related]  

  • 32. Antigen and vaccine banks: technical requirements and the role of the european antigen bank in emergency foot and mouth disease vaccination.
    Lombard M; Füssel AE
    Rev Sci Tech; 2007 Apr; 26(1):117-34. PubMed ID: 17633297
    [TBL] [Abstract][Full Text] [Related]  

  • 33. FMD and the contiguous cull.
    Wingfield A; Middlemiss C; Eppink L; Einshoj P
    Vet Rec; 2004 Nov; 155(20):647. PubMed ID: 15573794
    [No Abstract]   [Full Text] [Related]  

  • 34. FMD and the contiguous cull.
    Cook JG
    Vet Rec; 2004 Nov; 155(20):646-7. PubMed ID: 15573793
    [No Abstract]   [Full Text] [Related]  

  • 35. Foot and mouth disease: facing the new dilemmas.
    Thomson G
    Rev Sci Tech; 2002 Dec; 21(3):425-8. PubMed ID: 12523683
    [No Abstract]   [Full Text] [Related]  

  • 36. Effects of oxyamylose and polyacrylic acid on foot-and-mouth disease and hog cholera virus infections.
    Leunen J; Desmyter J; De Somer P
    Appl Microbiol; 1971 Feb; 21(2):203-8. PubMed ID: 5544281
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Some thoughts on FMD vaccine, outbreaks.
    Gerhart SB
    J Am Vet Med Assoc; 2003 Aug; 223(4):438. PubMed ID: 12930077
    [No Abstract]   [Full Text] [Related]  

  • 38. A dynamic, optimal disease control model for foot-and-mouth-disease: II. Model results and policy implications.
    Kobayashi M; Carpenter TE; Dickey BF; Howitt RE
    Prev Vet Med; 2007 May; 79(2-4):274-86. PubMed ID: 17280730
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Eradication versus vaccination strategies to control infectious diseases--some lessons to be learned from terrestrial animals.
    Moennig V
    Dev Biol (Basel); 2005; 121():13-9. PubMed ID: 15962466
    [TBL] [Abstract][Full Text] [Related]  

  • 40. FMD: movement restrictions eased in infected areas.
    Vet Rec; 2001 Jun; 148(26):795-6. PubMed ID: 11467604
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.